missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Bortezomib, MedChemExpress
Description
Bortezomib (PS-341) is a reversible and selective proteasome inhibitor, and potently inhibits 20S proteasome (Ki=0.6 nM) by targeting a threonine residue. Bortezomib disrupts the cell cycle, induces apoptosis, and inhibits NF-κB. Bortezomib is the first proteasome inhibitor anticancer agent. Anti-cancer activity.
Specifications
Specifications
| Chemical Name or Material | Bortezomib |
| CAS | 179324-69-7 |
| Color | White |
| Purity Grade Notes | Research |
| Molecular Formula | C19H25BN4O4 |
| Quantity | 100 mg |
| Synonym | PS-341 LDP-341 NSC 681239 |
| Solubility Information | Ethanol : 66.67 mg/mL (173.51 mM; ultrasonic and warming and heat to 60°C) ∣DMSO : 50 mg/mL (130.13 mM; Need ultrasonic) |
| SMILES | OB(O)[C@H](CC(C)C)NC([C@@H](NC(C1=NC=CN=C1)=O)CC2=CC=CC=C2)=O |
| Molecular Weight (g/mol) | 384.24 |
| Show More |
Research purposes only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?